RR
Readnour Robin Shane
董事
BoardM
内部人交易记录
董事尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the full record of transactions filed by Readnour Robin Shane, 董事. Director active across 1 company, notably AN2 Therapeutics, Inc.. Aggregated, 20 reports have been recorded. Breakdown: 8 buys · 10 sells. Total volume traded: €497k. History available since 10 January 2024. The latest transaction was filed on 9 September 2026 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Readnour Robin Shane
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报20 总计
523 股@ US$6.02430.0015% mcap0.0% 占其流量Common StockSEC:0001193125-26-389545:0
585 股@ US$6.02430.0017% mcap0.1% 占其流量Common StockSEC:0001193125-26-389545:1
2,877 股@ US$6.06980.0083% mcap0.3% 占其流量Common StockSEC:0001193125-26-385511:0
3,223 股@ US$6.06980.0093% mcap0.3% 占其流量Common StockSEC:0001193125-26-385511:1
4,725 股@ US$6.01830.014% mcap0.4% 占其流量Common StockSEC:0001193125-26-385511:2
5,294 股@ US$6.01830.015% mcap0.5% 占其流量Common StockSEC:0001193125-26-385511:3
16,696 股@ US$6.00820.045% mcap1.5% 占其流量Common StockSEC:0001193125-26-357225:0
18,706 股@ US$6.00820.050% mcap1.7% 占其流量Common StockSEC:0001193125-26-357225:1
9,077 股0Common StockSEC:0000950170-24-139792:0
12,711 股@ US$1.4457.8% 占其流量Common StockSEC:0000950170-24-135150:0
6,517 股@ US$1.44664.0% 占其流量Common StockSEC:0000950170-24-135150:1
12,289 股@ US$1.43037.4% 占其流量Common StockSEC:0000950170-24-135150:2
18,483 股@ US$1.428711.2% 占其流量Common StockSEC:0000950170-24-135150:3
5,000 股@ US$1.49243.2% 占其流量Common StockSEC:0000950170-24-135150:4
5,000 股@ US$1.49353.2% 占其流量Common StockSEC:0000950170-24-135150:5
12,500 股@ US$1.39347.5% 占其流量Common StockSEC:0000950170-24-131660:0
75,000 股@ US$1.033732.7% 占其流量Common StockSEC:0000950170-24-129830:0
706 股@ US$21.926.3% 占其流量Common StockSEC:0001209191-24-001770:0
1,869 股@ US$21.9316.8% 占其流量Common StockSEC:0001209191-24-001537:0
285,156 股Common StockSEC:0000899243-22-012991:0
About Readnour Robin Shane
Readnour Robin Shane is Administrateur at AN2 Therapeutics, Inc. (XNAS). The declarant has 12 filings in total, and across the 12 sampled filings dated from 2022-03-31 to 2024-12-23, the reported amounts are EUR 171882 of purchases and EUR 51584 of sales, with the most frequent transaction nature listed as Acquisition.